openPR Logo
Press release

Cancer Immunotherapy Market Overview 2020, Global Industry Report, Size and Analysis By F. Hoffmann-La Roche AG, Merck & Co., Inc., Novartis International AG, GlaxoSmithKline Plc., Amgen Inc.

02-18-2020 02:14 PM CET | Health & Medicine

Press release from: Market Research Future

Cancer Immunotherapy Market

Cancer Immunotherapy Market

Cancer Immunotherapy Market Research Report: By Type of Therapy (Monoclonal Antibodies, Adoptive Cell Transfer and others), By Application (Lung Cancer, Childhood Cancer and other), By End User (Hospitals, Clinics & others) - Global Forecast till 2023

Cancer Immunotherapy Market Overview:

Global market for Cancer Immunotherapy Market is following a growth track using which it can reach a valuation of USD 101.6 billion by 2023 with a healthy CAGR of 14.8% during the between 2017 and 2023. This time-frame has been considered by Market Research Future (MRFR) as the forecast period. The growth in the cancer immunotherapy market can be attributed to various features like the rise in recording of cancer patients, increasing technological interference, better growth possibilities in developing regions due to their rising investment in the healthcare sector, hike in government initiatives, along with private participation, transforming lifestyle where smoking, drinking, and food habits are showing considerable influence, and others can be taken into consideration for better market analysis. Also, the therapy has an advantage, that is its efficacy is quite high and side-effects are low. The treatment is quite effective for melanoma cancer where chemotherapy or other radiation therapies would not work.

Get a FREE Sample Copy of Report with Complete TOC @ https://www.marketresearchfuture.com/sample_request/567

Better growth in infrastructure and improving reimbursement policies are expected to provide traction to the global market for cancer immunotherapy. Constant innovation in the field is creating scope for the market to find better growth opportunities. However, the market may find hurdles in the form of high cost and lack of patient awareness.

Cancer Immunotherapy Market Segmentations

The global cancer immunotherapy market can be studied using segments having strong foundation in therapy types, application, and end user. These segments are also getting bolstered by information regarding various factors, valuations, and volumes.

By type, the market for Cancer Immunotherapy can be segmented into bacillus calmette-guérin, adoptive cell transfer, monoclonal antibodies, treatment vaccines, cytokines, and others. The Monoclonal antibodies segment includes conjugated monoclonal antibodies, naked monoclonal antibodies, and bispecific monoclonal antibodies. The cytokines segment comprises Interferon and Interleukins.

By application, the cancer immunotherapy market includes childhood cancer, lung cancer, liver cancer, stomach cancer, colorectal cancer, and others.

By end user, the market report for cancer immunotherapy can be segmented into hospitals, clinics, and others. The hospitals segment has provisions to rise with significant traction.

Cancer Immunotherapy Market Regional Analysis

The global market has the chance of gaining traction from regions like North America and Europe. These regions are known for their extensive market impact and it can be attributes to their robust infrastructure, better investment in research and development, high per capita income, Easy integration of technologies, better reimbursement policies, and others. Initiatives taken by governments and private players can influence the market growth.

The Asia Pacific market is witnessing high traction from several emerging economies where the healthcare sector is getting revamped. The speed is quite rapid, and it can be classed as the fastest CAGR during the forecast period. Massive patient population and hike in investment capacity are reasons that can impress the regional market in the coming years. In India, China, and South Korea, the growth would be prominent due to their hike in speed.

The Middle East and Africa (MEA) region can provide limited growth as the poor economies from the African market can hardly impact the market.

Cancer Immunotherapy Market Competitive Landscape:

Major players contributing in the growth of the global cancer immunotherapy market have been profiled by MRFR. The report made a significant tracking of the latest doing of these companies and how their decisions are going to change the market in the coming years. These companies are F. Hoffmann-La Roche AG, Merck & Co., Inc., Novartis International AG, GlaxoSmithKline Plc., Celgene Corporation, Bristol-Myers Squibb, Amgen Inc., Spectrum Pharmaceuticals, Inc. ELI Lilly and Company, Seattle Genetics, Inc., and others.

In October 2019, researchers from the Washington University School of Medicine in St. Louis revealed that the primary treatment process in cancer immunotherapy involves triggering T Cells. But if they get help from other T cells, commonly known as helper T cells, they can perform better.

Get More Information on Cancer Immunotherapy Market Research Report- Forecast till 2023 @ https://www.marketresearchfuture.com/reports/global-cancer-immunotherapy-market-567

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer Immunotherapy Market Overview 2020, Global Industry Report, Size and Analysis By F. Hoffmann-La Roche AG, Merck & Co., Inc., Novartis International AG, GlaxoSmithKline Plc., Amgen Inc. here

News-ID: 1936209 • Views: 340

More Releases from Market Research Future

Autism Disorder and Treatment Market Pipeline Review and Industry Trend Analysis …
The global autism disorder and treatment market is expected to exhibit a CAGR of 4.37% over the forecast period from 2017 to 2023, according to a new report from Market Research Future (MRFR). The global autism disorder and treatment market was valued at USD 5,143.6 million in 2016 and is likely to exhibit rapid growth over the forecast period due to the rising awareness about autism spectrum disorders (ASD) and…
Neurorehabilitation Devices Market Analysis By Top Companies : Hocoma AG, Ekso B …
Neurorehabilitation Devices Market Analysis  The neurorehabilitation devices market is anticipated to touch USD 2.25 billion between 2013-2022, states the latest Market Research Future (MRFR) report. Neurorehabilitation devices are therapeutic devices that are utilized in rehabilitation programs. It deals with daunting challenges to learn to live with different neurological conditions including amyotrophic lateral sclerosis, peripheral nervous disorders, spinal cord injuries, brain tremor, multiple sclerosis, Parkinson's disease, epilepsy, ADHD, and Alzheimer's disease. Besides,…
Microfluidics Devices Market Technology Improvements, Industry Share, Global Tre …
Detail Analysis of Global Microfluidics Devices Market with respect to region specific market growth and competitive analysis on the basis of major players present in the market. Detail analysis on possible segments and sub segments of the market. Along with this regional analysis of the market which includes America, Europe, Asia Pacific and Middle East and Africa. Forecast till 2023 The Microfluidics Devices Market is continually growing mainly due to the…
Clear Aligners Market Size 2020, Share, Industry Growth, Global Analysis, Resear …
Global Clear Aligners Market Research Report: Information by Product Type (Hard, Medium and Soft), Age (Adult and Teenager), Distribution Channel (Direct Sales and Laboratories) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2025 Clear Aligners Market Overview Global Clear Aligners Market size is expected to register 20.80% CAGR and is anticipated to reach USD 7019.96 Million by 2025, according to the latest market research report from…

All 5 Releases


More Releases for Cancer

Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular…
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top…
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized…
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and…